TENAX THERAPEUTICS, INC. Purchase Agreements
15 Contracts & Agreements
- Form of Securities Purchase Agreement by and between Tenax Therapeutics, Inc. and the purchasers named therein (Filed With SEC on February 7, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on January 31, 2023)
- Securities Purchase Agreement for Units, dated as of May 17, 2022, by and between the Company and the Investor (Filed With SEC on May 20, 2022)
- Form of Securities Purchase Agreement for Class E Units and Class F Units, dated as of July 6, 2020, by and between the Company and the Investor (Filed With SEC on July 8, 2020)
- Form of Securities Purchase Agreement for Class C Units and Class D Units, dated as of July 6, 2020, by and between the Company and the Investor (Filed With SEC on July 8, 2020)
- Form of Securities Purchase Agreement, dated as of March 11, 2020, by and between the Company and the Investor (Filed With SEC on March 13, 2020)
- Asset Purchase Agreement by and between Oxygen Biotherapeutics, Inc., Life Newco, Inc., Phyxius Pharma, Inc., and the stockholders of Phyxius Pharma, Inc. dated October 21, 2013 (Filed With SEC on October 25, 2013)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 13, 2013)
- Form of Securities Purchase Agreement (Filed With SEC on July 25, 2013)
- Form of Securities Purchase Agreement (Filed With SEC on July 18, 2013)
- Form of Securities Purchase Agreement (Filed With SEC on July 17, 2013)
- Form of Securities Purchase Agreement (Filed With SEC on July 5, 2013)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 25, 2013)
- Form of Securities Purchase Agreement (Filed With SEC on December 9, 2011)
- Amendment No. 3 to Securities Purchase Agreement between the Company and Vatea Fund, dated November 14, 2011 (Filed With SEC on November 16, 2011)